MedPath
HSA Approval

GLIPIZIDE TABLET 5 mg

SIN10237P

GLIPIZIDE TABLET 5 mg

GLIPIZIDE TABLET 5 mg

October 10, 1998

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Therapeutic

Prescription Only

Formulation Information

TABLET

ORAL

Medical Information

A10BB07

glipizide

Manufacturer Information

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

PT ACTAVIS INDONESIA

Active Ingredients

GLIPIZIDE

5 mg

Glipizide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

GLIPIZIDE TABLET 5 mg - HSA Approval | MedPath